Biogen Idec Aktie [WKN: 789617 / ISIN: US09062X1037]
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Einfügen in | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Analysechart (Java) | Analysen |  Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Research Statis. | Vergleich | Insidertrades | Knock-outs | myfinanzen |
| Orderbuch | Stuttgart Realtime | RSS Feed | Analyse | im Forum | Fonds | |
| Historisch | Realtime Push | IR-Daten | ||||
Analysen zur Biogen Idec Inc.
| 06.08.2008 | Biogen Idec sell | UBS AG |  |
| 06.08.2008 | Biogen Idec sell | UBS AG | |
| 05.08.2008 | Biogen Idec equal-weight | Lehman Brothers Inc. |  |
| 05.08.2008 | Biogen Idec market perform | Rodman & Renshaw, LLC | |
| 05.08.2008 | Biogen Idec neutral | Cowen and Company, LLC | |
| 04.08.2008 | Biogen Idec equal-weight | Lehman Brothers Inc. | |
| 04.08.2008 | Biogen Idec neutral | Cowen and Company, LLC | |
| 04.08.2008 | Biogen Idec neutral | Credit Suisse Group | |
| 04.08.2008 | Biogen Idec equal-weight | Lehman Brothers Inc. | |
| 01.08.2008 | Biogen Idec sell | UBS AG | |
| 01.08.2008 | Biogen Idec neues Kursziel | Credit Suisse Group | |
| 01.08.2008 | Biogen Idec neutral | Robert W. Baird & Co. Incorporated | |
| 29.07.2008 | Biogen Idec kaufen | Nasd@q Inside |  |
| 24.07.2008 | Biogen Idec sell | UBS AG | |
| 24.07.2008 | Biogen Idec neues Kursziel | Goldman Sachs Group Inc. | |
| 24.07.2008 | Biogen Idec neues Kursziel | Lehman Brothers Inc. | |
| 23.07.2008 | Biogen Idec sector perform | RBC Capital Markets | |
| 23.07.2008 | Biogen Idec sell | UBS AG | |
| 22.07.2008 | Biogen Idec buy | Merrill Lynch & Co., Inc. | |
| 21.07.2008 | Biogen Idec sell | UBS AG | |
| 21.07.2008 | Biogen Idec sell | UBS AG | |
| 11.07.2008 | Biogen Idec spekulative Position | Frankfurter Tagesdienst | |
| 09.07.2008 | Biogen Idec equal weight | Lehman Brothers Inc. | |
| 28.05.2008 | Biogen Idec dabeibleiben | Der Aktionär | |
| 17.04.2008 | Biogen Idec equal weight | Lehman Brothers Inc. | |
| 17.04.2008 | Biogen Idec neutral | Credit Suisse Group | |
| 16.04.2008 | Biogen Idec neues Kursziel | RBC Capital Markets | |
| 10.04.2008 | Biogen IDEC dabeibleiben | Der Aktionär | |
| 03.04.2008 | Biogen Idec equal-weight | Lehman Brothers Inc. | |
| 12.03.2008 | Biogen Idec hold | Citigroup Corp. | |
| 05.03.2008 | Biogen Idec equal weight | Lehman Brothers Inc. | |
| 14.02.2008 | Biogen Idec equal-weight | Lehman Brothers Inc. | |
| 08.02.2008 | Biogen Idec sell | UBS AG | |
| 07.02.2008 | Biogen Idec neues Kursziel | Jefferies & Company Inc. | |
| 17.01.2008 | Biogen Idec buy | Banc of America Sec. | |
| 16.01.2008 | Biogen Idec sell | UBS AG | |
| 16.01.2008 | Biogen Idec neutral | Credit Suisse Group | |
| 15.01.2008 | Biogen Idec ein echter Biotech-Blue-Chip | Biotech-Report | |
| 03.01.2008 | Biogen Idec neues Kursziel | RBC Capital Markets | |
| 14.12.2007 | Biogen Idec neutral | Cowen and Company, LLC | |
Seite: 1 | 2 | 3 | 4 | 5  | |||
Hot Stocks der letzten 3 Tage nach Analysenanzahl
|
